In recent years, the pharmaceutical sector has grappled with significant challenges, from soaring raw material costs to supply chain disruptions. These factors are constraining profit margins as companies face mounting pressure, particularly from the U.S. government, to keep drug prices in check. Compounding these issues is the approaching expiration of numerous patents, which threatens the market position of established drugs. However, a transformative force is emerging: agentic AI. This advanced technology is set to redefine how pharmaceutical companies operate, streamlining processes, improving efficiency, and ultimately lowering costs. By harnessing the power of AI, the industry aims to navigate its current hurdles while fostering innovation in drug development and delivery. As the landscape evolves, agentic AI could be the key to not only surviving but thriving in a competitive market, ensuring that patients continue to receive essential medications at more affordable prices. With these advancements, the future of pharmaceuticals looks poised for a significant transformation.